Market revenue in 2024 | USD 68.5 million |
Market revenue in 2030 | USD 97.2 million |
Growth rate | 6% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 52.55% in 2024. Horizon Databook has segmented the Kuwait cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The primary factor driving the CRM device market in Kuwait is the increasing prevalence of heart diseases. Heart diseases, including coronary heart diseases, are a significant health concern in Kuwait, and the demand for CRM devices is directly influenced by the number of people affected by these conditions.
The government's initiatives to improve healthcare infrastructure and services have also played a significant role in the growth of the cardiac rhythm management devices market in Kuwait. The government has been investing heavily in healthcare infrastructure, including hospitals, clinics, and medical equipment, which has helped to improve the quality of healthcare services in the country.
This has made it easier for patients to access CRMDs and receive timely treatment for their heart conditions. In addition, Kuwait’s growing aging population contributes to market growth. As per the United Nations Population Fund’s World Population Dashboard data for 2021, around 3.4% of Kuwait’s population comprises individuals 65 and older.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account